Role of innate immunity and the microbiota in liver fibrosis: Crosstalk between the liver and gut

Journal of Physiology

Volumn 590, Issue 3, 2012, Pages 447-458

  Seki, Ekihiro ^a   Schnabl, Bernd ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9;

ALCOHOL LIVER CIRRHOSIS; BACTERIAL TRANSLOCATION; HUMAN; IMMUNOPATHOGENESIS; INNATE IMMUNITY; KUPFFER CELL; LIVER FIBROSIS; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION; STELLATE CELL;

ANIMALS; BACTERIAL TRANSLOCATION; GASTROINTESTINAL TRACT; HUMANS; IMMUNITY, INNATE; LIVER; LIVER CIRRHOSIS; LIVER DISEASES, ALCOHOLIC; METAGENOME; TOLL-LIKE RECEPTORS;

EID: 84856350648     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2011.219691     Document Type: Review

References (88)

1. Adachi Y, Bradford BU, Gao W, Bojes HK & Thurman RG (1994). Inactivation of Kupffer cells prevents early alcohol-induced liver injury. Hepatology 20, 453-460.
2. Adachi Y, Moore LE, Bradford BU, Gao W & Thurman RG (1995). Antibiotics prevent liver injury in rats following long-term exposure to ethanol. Gastroenterology 108, 218-224.
3. Assimakopoulos SF, Scopa CD & Vagianos CE (2007). Pathophysiology of increased intestinal permeability in obstructive jaundice. World J Gastroenterol 13, 6458-6464.
4. Backhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, Semenkovich CF & Gordon JI (2004). The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 101, 15718-15723.
5. Baeck C, Wehr A, Karlmark KR, Heymann F, Vucur M, Gassler N, Huss S, Klussmann S, Eulberg D, Luedde T, Trautwein C & Tacke F (2011). Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury. Gut (in press).
6. Bataller R & Brenner DA (2005). Liver fibrosis. J Clin Invest 115, 209-218.
7. Berg RD & Garlington AW (1979). Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in a gnotobiotic mouse model. Infect Immun 23, 403-411.
8. Berres ML, Koenen RR, Rueland A, Zaldivar MM, Heinrichs D, Sahin H, Schmitz P, Streetz KL, Berg T, Gassler N, Weiskirchen R, Proudfoot A, Weber C, Trautwein C & Wasmuth HE (2010). Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice. J Clin Invest 120, 4129-4140.
9. Bode C & Bode JC (2003). Effect of alcohol consumption on the gut. Best Pract Res Clin Gastroenterol 17, 575-592.
10. Bode C, Kugler V & Bode JC (1987). Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess. J Hepatol 4, 8-14.
11. Chan CC, Hwang SJ, Lee FY, Wang SS, Chang FY, Li CP, Chu CJ, Lu RH & Lee SD (1997). Prognostic value of plasma endotoxin levels in patients with cirrhosis. Scand J Gastroenterol 32, 942-946.
12. Chen GY & Nunez G (2010). Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol 10, 826-837.
13. Chen Y, Yang F, Lu H, Wang B, Lei D, Wang Y, Zhu B & Li L (2011). Characterization of fecal microbial communities in patients with liver cirrhosis. Hepatology 54, 562-572.
14. Crispe IN (2009). The liver as a lymphoid organ. Annu Rev Immunol 27, 147-163.
15. Csak T, Velayudham A, Hritz I, Petrasek J, Levin I, Lippai D, Catalano D, Mandrekar P, Dolganiuc A, Kurt-Jones E & Szabo G (2011). Deficiency in myeloid differentiation factor-2 and toll-like receptor 4 expression attenuates nonalcoholic steatohepatitis and fibrosis in mice. Am J Physiol Gastrointest Liver Physiol 300, G433-441.
16. Friedman SL (2008). Mechanisms of hepatic fibrogenesis. Gastroenterology 134, 1655-1669.
17. Fukui H, Brauner B, Bode JC & Bode C (1991). Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay. J Hepatol 12, 162-169.
18. Gao B (2011). Innate immunity and steatohepatitis: a critical role of another toll (TLR-9). Gastroenterology 139, 27-30.
19. 4-induced fibrosis. PLoS One 6, e23037.
20. Grinko I, Geerts A & Wisse E (1995). Experimental biliary fibrosis correlates with increased numbers of fat-storing and Kupffer cells, and portal endotoxemia. J Hepatol 23, 449-458.
21. Gunnarsdottir SA, Sadik R, Shev S, Simren M, Sjovall H, Stotzer PO, Abrahamsson H, Olsson R & Bjornsson ES (2003). Small intestinal motility disturbances and bacterial overgrowth in patients with liver cirrhosis and portal hypertension. Am J Gastroenterol 98, 1362-1370.
22. Higashiyama R, Moro T, Nakao S, Mikami K, Fukumitsu H, Ueda Y, Ikeda K, Adachi E, Bou-Gharios G, Okazaki I & Inagaki Y (2009). Negligible contribution of bone marrow-derived cells to collagen production during hepatic fibrogenesis in mice. Gastroenterology 137, 1459-1466.
23. Hritz I, Mandrekar P, Velayudham A, Catalano D, Dolganiuc A, Kodys K, Kurt-Jones E & Szabo G (2008a). The critical role of toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88. Hepatology 48, 1224-1231.
24. Hritz I, Velayudham A, Dolganiuc A, Kodys K, Mandrekar P, Kurt-Jones E & Szabo G (2008b). Bone marrow-derived immune cells mediate sensitization to liver injury in a myeloid differentiation factor 88-dependent fashion. Hepatology 48, 1342-1347.
25. Huang H, Shiffman ML, Friedman S, Venkatesh R, Bzowej N, Abar OT, Rowland CM, Catanese JJ, Leong DU, Sninsky JJ, Layden TJ, Wright TL, White T & Cheung RC (2007). A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C. Hepatology 46, 297-306.
26. Imamura M, Tsutsui H, Yasuda K, Uchiyama R, Yumikura-Futatsugi S, Mitani K, Hayashi S, Akira S, Taniguchi S, Van Rooijen N, Tschopp J, Yamamoto T, Fujimoto J & Nakanishi K (2009). Contribution of TIR domain-containing adapter inducing IFN-β-mediated IL-18 release to LPS-induced liver injury in mice. J Hepatol 51, 333-341.
27. Inokuchi S, Tsukamoto H, Park EJ, Liu Z-X, Brenner DA & Seki E (2011). Toll-like receptor 4 mediates alcohol-induced steatohepatitis through bone marrow-derived and endogenous liver cells in mice. Alcohol Clin Exp Res 35, 1509-1518.
28. Isayama F, Hines IN, Kremer M, Milton RJ, Byrd CL, Perry AW, McKim SE, Parsons C, Rippe RA & Wheeler MD (2006). LPS signaling enhances hepatic fibrogenesis caused by experimental cholestasis in mice. Am J Physiol Gastrointest Liver Physiol 290, G1318-1328.
29. Isogawa M, Robek MD, Furuichi Y & Chisari FV (2005). Toll-like receptor signaling inhibits hepatitis B virus replication in vivo. J Virol 79, 7269-7272.
30. Karlmark KR, Weiskirchen R, Zimmermann HW, Gassler N, Ginhoux F, Weber C, Merad M, Luedde T, Trautwein C & Tacke F (2009). Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis. Hepatology 50, 261-274.
31. Kennedy DW & Abkowitz JL (1997). Kinetics of central nervous system microglial and macrophage engraftment: analysis using a transgenic bone marrow transplantation model. Blood 90, 986-993.
32. Kim JJ & Sears DD (2010). TLR4 and insulin resistance. Gastroenterol Res Pract 2010, 212563.
33. Kisseleva T, Uchinami H, Feirt N, Quintana-Bustamante O, Segovia JC, Schwabe RF & Brenner DA (2006). Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. J Hepatol 45, 429-438.
34. Klein I, Cornejo JC, Polakos NK, John B, Wuensch SA, Topham DJ, Pierce RH & Crispe IN (2007). Kupffer cell heterogeneity: functional properties of bone marrow derived and sessile hepatic macrophages. Blood 110, 4077-4085.
35. Ley RE, Turnbaugh PJ, Klein S & Gordon JI (2006). Microbial ecology: human gut microbes associated with obesity. Nature 444, 1022-1023.
36. Li L, Chen L, Hu L, Liu Y, Sun HY, Tang J, Hou YJ, Chang YX, Tu QQ, Feng GS, Shen F, Wu MC & Wang HY (2011). Nuclear factor high-mobility group box1 mediating the activation of toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice. Hepatology 54, 1620-1630.
37. Lin RS, Lee FY, Lee SD, Tsai YT, Lin HC, Lu RH, Hsu WC, Huang CC, Wang SS & Lo KJ (1995). Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation. J Hepatol 22, 165-172.
38. Lu H, Wu Z, Xu W, Yang J, Chen Y & Li L (2011). Intestinal microbiota was assessed in cirrhotic patients with hepatitis B virus infection. Intestinal microbiota of HBV cirrhotic patients. Microb Ecol 61, 693-703.
39. Ma TY, Nguyen D, Bui V, Nguyen H & Hoa N (1999). Ethanol modulation of intestinal epithelial tight junction barrier. Am J Physiol Gastrointest Liver Physiol 276, G965-974.
40. Marra F (2002). Chemokines in liver inflammation and fibrosis. Front Biosci 7, d1899-1914.
41. Marra F, Romanelli RG, Giannini C, Failli P, Pastacaldi S, Arrighi MC, Pinzani M, Laffi G, Montalto P & Gentilini P (1999). Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells. Hepatology 29, 140-148.
42. Miele L, Valenza V, La Torre G, Montalto M, Cammarota G, Ricci R, Masciana R, Forgione A, Gabrieli ML, Perotti G, Vecchio FM, Rapaccini G, Gasbarrini G, Day CP & Grieco A (2009). Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology 49, 1877-1887.
43. Miettinen TA (1972). Lipid absorption, bile acids, and cholesterol metabolism in patients with chronic liver disease. Gut 13, 682-689.
44. Miura K, Kodama Y, Inokuchi S, Schnabl B, Aoyama T, Ohnishi H, Olefsky JM, Brenner DA & Seki E (2010a). Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1β in mice. Gastroenterology 139, 323-334.
45. Miura K, Seki E, Ohnishi H & Brenner DA (2010b). Role of toll-like receptors and their downstream molecules in the development of nonalcoholic fatty liver disease. Gastroenterol Res Pract 2010, 362847.
46. Mutlu E, Keshavarzian A, Engen P, Forsyth CB, Sikaroodi M & Gillevet P (2009). Intestinal dysbiosis: a possible mechanism of alcohol-induced endotoxemia and alcoholic steatohepatitis in rats. Alcohol Clin Exp Res 33, 1836-1846.
47. Nanji AA, Khettry U & Sadrzadeh SM (1994). Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver (disease). Proc Soc Exp Biol Med 205, 243-247.
48. Nolan JP & Leibowitz AI (1978). Endotoxin and the liver. III. Modification of acute carbon tetrachloride injury by polymyxin b - an antiendotoxin. Gastroenterology 75, 445-449.
49. Paik YH, Schwabe RF, Bataller R, Russo MP, Jobin C & Brenner DA (2003). Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells. Hepatology 37, 1043-1055.
50. Pennington HL, Hall PM, Wilce PA & Worrall S (1997). Ethanol feeding enhances inflammatory cytokine expression in lipopolysaccharide-induced hepatitis. J Gastroenterol Hepatol 12, 305-313.
51. Petrasek J, Dolganiuc A, Csak T, Nath B, Hritz I, Kodys K, Catalano D, Kurt-Jones E, Mandrekar P & Szabo G (2011). Interferon regulatory factor 3 and type I interferons are protective in alcoholic liver injury in mice by way of crosstalk of parenchymal and myeloid cells. Hepatology 53, 649-660.
52. Petrasek J, Mandrekar P & Szabo G (2010). Toll-like receptors in the pathogenesis of alcoholic liver disease. Gastroenterol Res Pract 2010, 710381.
53. Pradere JP, Troeger JS, Dapito DH, Mencin AA & Schwabe RF (2010). Toll-like receptor 4 and hepatic fibrogenesis. Semin Liver Dis 30, 232-244.
54. Pulskens WP, Rampanelli E, Teske GJ, Butter LM, Claessen N, Luirink IK, van der Poll T, Florquin S & Leemans JC (2011). TLR4 promotes fibrosis but attenuates tubular damage in progressive renal injury. J Am Soc Nephrol 21, 1299-1308.
55. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S & Medzhitov R (2004). Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118, 229-241.
56. Rao R (2009). Endotoxemia and gut barrier dysfunction in alcoholic liver disease. Hepatology 50, 638-644.
57. Rivera CA, Adegboyega P, van Rooijen N, Tagalicud A, Allman M & Wallace M (2007). Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis. J Hepatol 47, 571-579.
58. Roderburg C, Urban GW, Bettermann K, Vucur M, Zimmermann H, Schmidt S, Janssen J, Koppe C, Knolle P, Castoldi M, Tacke F, Trautwein C & Luedde T (2011). Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology 53, 209-218.
59. Schwabe RF, Bataller R & Brenner DA (2003). Human hepatic stellate cells express CCR5 and RANTES to induce proliferation and migration. Am J Physiol Gastrointest Liver Physiol 285, G949-958.
60. Seki E & Brenner DA (2008). Toll-like receptors and adaptor molecules in liver disease: update. Hepatology 48, 322-335.
61. Seki E, De Minicis S, Gwak GY, Kluwe J, Inokuchi S, Bursill CA, Llovet JM, Brenner DA & Schwabe RF (2009a). CCR1 and CCR5 promote hepatic fibrosis in mice. J Clin Invest 119, 1858-1870.
62. Seki E, de Minicis S, Inokuchi S, Taura K, Miyai K, van Rooijen N, Schwabe RF & Brenner DA (2009b). CCR2 promotes hepatic fibrosis in mice. Hepatology 50, 185-197.
63. Seki E, De Minicis S, Osterreicher CH, Kluwe J, Osawa Y, Brenner DA & Schwabe RF (2007). TLR4 enhances TGF-β signaling and hepatic fibrosis. Nat Med 13, 1324-1332.
64. Seki E, Tsutsui H, Iimuro Y, Naka T, Son G, Akira S, Kishimoto T, Nakanishi K & Fujimoto J (2005). Contribution of Toll-like receptor/myeloid differentiation factor 88 signaling to murine liver regeneration. Hepatology 41, 443-450.
65. Seki E, Tsutsui H, Nakano H, Tsuji N, Hoshino K, Adachi O, Adachi K, Futatsugi S, Kuida K, Takeuchi O, Okamura H, Fujimoto J, Akira S & Nakanishi K (2001). Lipopolysaccharide-induced IL-18 secretion from murine Kupffer cells independently of myeloid differentiation factor 88 that is critically involved in induction of production of IL-12 and IL-1β. J Immunol 166, 2651-2657.
66. Son G, Kremer M & Hines IN (2010). Contribution of gut bacteria to liver pathobiology. Gastroenterol Res Pract 2010, 453563.
67. Sonnenburg JL, Chen CT & Gordon JI (2006). Genomic and metabolic studies of the impact of probiotics on a model gut symbiont and host. PLoS Biol 4, e413.
68. Sorrentino P, Terracciano L, D'Angelo S, Ferbo U, Bracigliano A & Vecchione R (2010). Predicting fibrosis worsening in obese patients with NASH through parenchymal fibronectin, HOMA-IR, and hypertension. Am J Gastroenterol 105, 336-344.
69. Spruss A, Kanuri G, Wagnerberger S, Haub S, Bischoff SC & Bergheim I (2009). Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice. Hepatology 50, 1094-1104.
70. Sung JY, Shaffer EA & Costerton JW (1993). Antibacterial activity of bile salts against common biliary pathogens. Effects of hydrophobicity of the molecule and in the presence of phospholipids. Dig Dis Sci 38, 2104-2112.
71. Szabo G & Bala S (2010). Alcoholic liver disease and the gut-liver axis. World J Gastroenterol 16, 1321-1329.
72. Takeuchi O & Akira S (2010). Pattern recognition receptors and inflammation. Cell 140, 805-820.
73. Tseng PH, Matsuzawa A, Zhang W, Mino T, Vignali DA & Karin M (2010). Different modes of ubiquitination of the adaptor TRAF3 selectively activate the expression of type I interferons and proinflammatory cytokines. Nat Immunol 11, 70-75.
74. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER & Gordon JI (2006). An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027-1031.
75. Uesugi T, Froh M, Arteel GE, Bradford BU & Thurman RG (2001). Toll-like receptor 4 is involved in the mechanism of early alcohol-induced liver injury in mice. Hepatology 34, 101-108.
76. Uesugi T, Froh M, Arteel GE, Bradford BU, Wheeler MD, Gabele E, Isayama F & Thurman RG (2002). Role of lipopolysaccharide-binding protein in early alcohol-induced liver injury in mice. J Immunol 168, 2963-2969.
77. Vanni E & Bugianesi E (2009). The gut-liver axis in nonalcoholic fatty liver disease: Another pathway to insulin resistance? Hepatology 49, 1790-1792.
78. von Montfort C, Beier JI, Guo L, Kaiser JP & Arteel GE (2008). Contribution of the sympathetic hormone epinephrine to the sensitizing effect of ethanol on LPS-induced liver damage in mice. Am J Physiol Gastrointest Liver Physiol 294, G1227-1234.
79. Wang B, Trippler M, Pei R, Lu M, Broering R, Gerken G & Schlaak JF (2009). Toll-like receptor activated human and murine hepatic stellate cells are potent regulators of hepatitis C virus replication. J Hepatol 51, 1037-1045.
80. Wen L, Ley RE, Volchkov PY, Stranges PB, Avanesyan L, Stonebraker AC, Hu C, Wong FS, Szot GL, Bluestone JA, Gordon JI & Chervonsky AV (2008). Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 455, 1109-1113.
81. Wiest R & Garcia-Tsao G (2005). Bacterial translocation (BT) in cirrhosis. Hepatology 41, 422-433.
82. Wu J, Meng Z, Jiang M, Zhang E, Trippler M, Broering R, Bucchi A, Krux F, Dittmer U, Yang D, Roggendorf M, Gerken G, Lu M & Schlaak JF (2010). Toll-like receptor-induced innate immune responses in non-parenchymal liver cells are cell type-specific. Immunology 129, 363-374.
83. Yamamoto M & Takeda K (2010). Current views of toll-like receptor signaling pathways. Gastroenterol Res Pract 2010, 240365.
84. Yan AW, Fouts DE, Brandl J, Starkel P, Torralba M, Schott E, Tsukamoto H, Nelson KE, Brenner DA & Schnabl B (2011). Enteric dysbiosis associated with a mouse model of alcoholic liver disease. Hepatology 53, 96-105.
85. Yan X, Lin Z, Chen F, Zhao X, Chen H, Ning Y & Chen YG (2009). Human BAMBI cooperates with Smad7 to inhibit transforming growth factor-β signaling. J Biol Chem 284, 30097-30104.
86. Yin M, Bradford BU, Wheeler MD, Uesugi T, Froh M, Goyert SM & Thurman RG (2001). Reduced early alcohol-induced liver injury in CD14-deficient mice. J Immunol 166, 4737-4742.
87. Yu LX, Yan HX, Liu Q, Yang W, Wu HP, Dong W, Tang L, Lin Y, He YQ, Zou SS, Wang C, Zhang HL, Cao GW, Wu MC & Wang HY (2010). Endotoxin accumulation prevents carcinogen-induced apoptosis and promotes liver tumorigenesis in rodents. Hepatology 52, 1322-1333.
88. Zhang W, Gu Y, Chen Y, Deng H, Chen L, Chen S, Zhang G & Gao Z (2010). Intestinal flora imbalance results in altered bacterial translocation and liver function in rats with experimental cirrhosis. Eur J Gastroenterol Hepatol 22, 1481-1486.